Insight Molecular Diagnostics Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $74.9M
Liabilities Breakdown FY2023
Total Liabilities: $49.3M
Asset Breakdown
Total Assets: $74.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $9.4M | 12.6% |
| Accounts Receivable | $484.0K | 0.6% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.7M | 6.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $56.6M | 75.6% |
| Other Assets | $3.7M | 4.9% |
Liabilities Breakdown
Total Liabilities: $49.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $953.0K | 1.9% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $48.3M | 98.1% |